436 related articles for article (PubMed ID: 9693685)
1. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
Arunthathi S; Raju S
Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
[TBL] [Abstract][Full Text] [Related]
2. Dapsone induced eosinophilic pneumonia.
Adar T; Tayer-Shifman O; Mizrahi M; Tavdi S; Barak O; Shalit M
Eur Ann Allergy Clin Immunol; 2012 Jun; 44(3):144-6. PubMed ID: 22905598
[TBL] [Abstract][Full Text] [Related]
3. Dapsone-induced photosensitivity: a rare clinical presentation.
Kar BR
Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):270-1. PubMed ID: 18811870
[TBL] [Abstract][Full Text] [Related]
4. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
[TBL] [Abstract][Full Text] [Related]
5. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
De D; Dogra S; Kaur I
Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
[TBL] [Abstract][Full Text] [Related]
6. Dapsone-induced eosinophilic pneumonitis in a leprosy patient.
Kaur J; Khandpur S; Seith A; Khanna N
Indian J Lepr; 2005; 77(3):267-71. PubMed ID: 16353525
[TBL] [Abstract][Full Text] [Related]
7. Neonatal methemoglobinemia due to transplacental transfer of dapsone.
Kabra NS; Nanavati RN; Srinivasan G
Indian Pediatr; 1998 Jun; 35(6):553-5. PubMed ID: 10216653
[No Abstract] [Full Text] [Related]
8. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
[No Abstract] [Full Text] [Related]
9. Dapsone induced cholangitis as a part of dapsone syndrome: a case report.
Itha S; Kumar A; Dhingra S; Choudhuri G
BMC Gastroenterol; 2003 Aug; 3():21. PubMed ID: 12911838
[TBL] [Abstract][Full Text] [Related]
10. [Immuno-allergic accidents with rifamipcin].
Flageul B; Wagner L; Cottenot F
Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
[TBL] [Abstract][Full Text] [Related]
11. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
[TBL] [Abstract][Full Text] [Related]
12. T-cell plasticity of dapsone and DRESS.
Markova A; Duquesnoy R; Levis W
J Drugs Dermatol; 2014 Jan; 13(1):12-3. PubMed ID: 24385113
[No Abstract] [Full Text] [Related]
13. Renal hypersensitivity vasculitis associated with dapsone.
Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
[TBL] [Abstract][Full Text] [Related]
14. Dapsone syndrome in a Filipino man.
Hortaleza AR; Salta-Ramos NG; Barcelona-Tan J; Abad-Venida L
Lepr Rev; 1995 Dec; 66(4):307-13. PubMed ID: 8637384
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia.
Ashurst JV; Wasson MN; Hauger W; Fritz WT
J Am Osteopath Assoc; 2010 Jan; 110(1):16-20. PubMed ID: 20093649
[TBL] [Abstract][Full Text] [Related]
16. Hematological alterations in lepromatous leprosy: A cross-sectional observational study.
Gupta B; Gupta S; Chaudhary M; Raj AT; Awan KH; Patil S
Dis Mon; 2020 Jul; 66(7):100919. PubMed ID: 31796205
[TBL] [Abstract][Full Text] [Related]
17. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
[TBL] [Abstract][Full Text] [Related]
18. [Leprosy with an unusual course].
Desenfants A; Huguon E; Polfrit Y; Crouzat M; Rouleau V; Chassot V; Besson-Leaud L; Missotte I
Arch Pediatr; 2012 Nov; 19(11):1182-6. PubMed ID: 23037580
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine.
Matono T; Suzuki S; Mori S; Ato M
Am J Trop Med Hyg; 2024 Mar; 110(3):483-486. PubMed ID: 38266303
[TBL] [Abstract][Full Text] [Related]
20. Modification of multidrug treatment of leprosy in Vanuatu.
Reeve PA; Ala J; Hall JJ
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):655-6. PubMed ID: 1299719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
